Items Tagged ‘citalopram’

Genome-Wide Associations of Citalopram and Escitalopram Plasma Drug and Metabolite Concentrations

July 15, 2014

Genome-Wide Associations of Citalopram and Escitalopram Plasma Drug and Metabolite Concentrations

By Center for Individualized Medicine Center for Individualized Medicine

    Published in the British Journal of Clinical Pharmacology, a team of researchers from the Mayo Clinic, led by the director of the Center for Individualized Medicine’s Pharmacogenomics Program, Richard Weinshilboum, M.D., applied a genome-wide association study (GWAS) to identify genetic factors that contribute to variation in plasma concentrations of Citalopram (CT) or escitalopram (S-CT), and […]

View full entry

Tags: center for individualized medicine, citalopram, DNA, DNA Sequencing, dna test, DNA Testing, escitalopram, gene sequencing, genetic, Genetics, genome, genome science


March 13, 2014

Citalopram and Escitalopram Plasma Drug and Metabolite Concentrations: Genome-Wide Associations

By Mystery User

A recently published article in the area of Pharmacogenomics set out to identify genetic factors in Citalopram (CT) and escitalopram (S-CT), which are among the most widely prescribed serotonin reuptake inhibitors (SSRIs) used to treat Major Depressive Disorder (MDD), that contribute to variation in plasma concentrations of CT or S-CT and their metabolites in MDD patients treated […]

View full entry

Tags: citalopram, dna test, DNA Testing, escitalopram, gene sequencing, genome science, genome-wide association studies, genomic medicine, genomics, individualized medicine, major depressive disorder, personal genomics


Contact Us · Privacy Policy